MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions
The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with...
Saved in:
Published in | Arthritis research & therapy Vol. 22; no. 1; pp. 74 - 8 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
09.04.2020
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort.
A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects.
A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10
). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10
), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10
). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10
), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians.
This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B. |
---|---|
AbstractList | The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort.BACKGROUNDThe association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort.A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects.METHODSA total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects.A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10-244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10-19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10-4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10-241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians.RESULTSA strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10-244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10-19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10-4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10-241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians.This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B.CONCLUSIONSThis study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B. The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10 ). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10 ), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10 ). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10 ), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B. Abstract Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. Methods A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. Results A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10−244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10−19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10−4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10−241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. Conclusions This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B. Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. Methods A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. Results A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 × 10−244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 × 10−19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 × 10−4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 × 10−241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. Conclusions This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B. Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. Methods A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. Results A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 x 10.sup.-244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 x 10.sup.-19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 x 10.sup.-4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 x 10.sup.-241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. Conclusions This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B. Keywords: Ankylosing spondylitis, HLA, Association The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong evidence indicating that other HLA-B alleles are involved in the disease. European ethnicity studies have demonstrated risk associations with HLA-B*40 and multiple other HLA-B, HLA-A, and HLA class II alleles, and demonstrated that in that ethnic group, the amino acid sequence at position 97 in HLA-B is the key determinant of HLA associations with AS. A recent study in Korean AS cases and controls additionally identified association at HLA-C*15:02. In the current study, we examined the MHC associations of AS in an expanded East Asian cohort. A total of 1637 Chinese, Taiwanese, and Korean AS cases meeting the modified New York Criteria for AS, and 1589 ethnically matched controls, were genotyped with the Illumina Immunochip, including a dense coverage of the MHC region. HLA genotypes and amino acid composition were imputed using the SNP2HLA programme using the Han-MHC reference panel based on the data of Han Chinese subjects (n = 9689), and association tested using logistic regression controlling for population stratification effects. A strong association was seen with HLA-B*27 (odds ratio (OR) = 205.3, P = 5.76 x 10.sup.-244). Controlling for this association, the strongest risk association is seen with HLA-C*15 at genome-wide significant level (OR = 7.62, P = 9.30 x 10.sup.-19), and confirmed association is also seen with HLA-B*40 at suggestive level (OR = 1.65, P = 2.54 x 10.sup.-4). At amino acid level, the strongest association seen in uncontrolled analysis was with histidine at position 114 in HLA-B (P = 7.24 x 10.sup.-241), but conditional analyses suggest that the primary amino acid associations are with lysine at position 70 and asparagine at position 97. Restriction of the ERAP1 association with HLA-B27-positive AS, previously reported in European subjects, was confirmed in East Asians. This study confirms in East Asians that the HLA associations of AS are multiple, including previously reported associations at HLA-B*27, HLA-B*40, and HLA-C*15, as well as novel association with HLA-DQB1*04. The HLA-B associations are driven by the amino acids at positions 70 and 97, in the B pocket of HLA-B. |
ArticleNumber | 74 |
Audience | Academic |
Author | Bang, So-Young Li, Zhixiu Kim, Kwangwoo Brown, Matthew A. Kim, Tae-Hwan Xu, Huji Cortes, Adrian Leo, Paul Wang, Geng |
Author_xml | – sequence: 1 givenname: Geng surname: Wang fullname: Wang, Geng – sequence: 2 givenname: Tae-Hwan surname: Kim fullname: Kim, Tae-Hwan – sequence: 3 givenname: Zhixiu surname: Li fullname: Li, Zhixiu – sequence: 4 givenname: Adrian surname: Cortes fullname: Cortes, Adrian – sequence: 5 givenname: Kwangwoo surname: Kim fullname: Kim, Kwangwoo – sequence: 6 givenname: So-Young surname: Bang fullname: Bang, So-Young – sequence: 7 givenname: Paul surname: Leo fullname: Leo, Paul – sequence: 8 givenname: Matthew A. surname: Brown fullname: Brown, Matthew A. – sequence: 9 givenname: Huji surname: Xu fullname: Xu, Huji |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32272966$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks2O0zAURiM0iPmBF2CBIrFhk8G-Tmxng9SpBjpSERtYW7ZjF5fULnFa0bfntp2B6QihKLJln3uSa3-XxVlM0RXFa0quKZX8faaMiKYiQPCltayaZ8UFrYWsOONw9mh-XlzmvCQEoIX6RXHOAAS0nF8U6fNsWuqckw16DCnmMvlSxx-7PuUQF2Vep9jt-jCGXIZY3uo8lpMcNIJ6cKVNq3XvfmFFh9vb1G9diX9ZzeaT6gZEiSMycRyC2Rz0L4vnXvfZvbofr4pvH2-_TmfV_Munu-lkXtmGs7FqvLC2lcw7aTxvCaOESWM6LltBWMMk5a4zDRWMe8KBO2OFpcQzINpQK9hVcXf0dkkv1XoIKz3sVNJBHRbSsFB6GIPtnWKG0RYM07SBmoGVxONhGrC8pV3nCLo-HF3rjVm5zjrsR_cn0tOdGL6rRdoqQWveygYF7-4FQ_q5cXlUq5Ct63sdXdpkBUxKCQC1RPTtE3SZNkPEo0KqpSDw6uq_1EJjAyH6hN-1e6macGQYpaJF6vofFD6dWwW8FecDrp8UvHnc6J8OH-KCgDwCdkg5D84rG8ZDbtAcekWJ2idTHZOpMJnqkEy1PwN4Uvpg_0_Rb8T84t8 |
CitedBy_id | crossref_primary_10_3389_fimmu_2022_838891 crossref_primary_10_4103_NJPT_NJPT_2_24 crossref_primary_10_1007_s00125_021_05476_6 crossref_primary_10_3390_ijms25116081 crossref_primary_10_1111_1756_185X_14846 crossref_primary_10_3389_fgene_2021_671682 crossref_primary_10_1016_j_berh_2024_101982 crossref_primary_10_4103_aam_aam_180_23 crossref_primary_10_1097_BOR_0000000000000946 crossref_primary_10_1007_s11926_022_01079_1 crossref_primary_10_1136_rmdopen_2024_004589 crossref_primary_10_1111_1756_185X_14055 crossref_primary_10_4078_jrd_2023_0041 crossref_primary_10_1136_ard_2022_222852 crossref_primary_10_3389_fimmu_2023_1104351 crossref_primary_10_1016_j_mehy_2022_111000 crossref_primary_10_2478_rrlm_2023_0012 |
Cites_doi | 10.1038/ng.1047 10.1038/ng.873 10.1073/pnas.1618856114 10.1002/anr.1780320912 10.2174/1874312920130628001 10.1086/519795 10.1186/ar3204 10.1038/ng.3576 10.1038/ng.3656 10.1038/ng.1005 10.1186/ar3855 10.1038/ncomms8146 10.3899/jrheum.151096 10.1093/rheumatology/keh193 10.1371/journal.pone.0007888 10.1002/art.1780270401 10.1038/ng.2667 10.1186/s13075-015-0855-3 10.1136/ard.55.4.268 10.1007/s00251-015-0849-y |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2020 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s13075-020-02148-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1478-6362 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_3b3192b3a152432c80f148b2c691dde0 PMC7146985 A627331179 32272966 10_1186_s13075_020_02148_5 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China Republic of Korea Taiwan South Korea Asia |
GeographicLocations_xml | – name: China – name: Republic of Korea – name: Taiwan – name: South Korea – name: Asia |
GrantInformation_xml | – fundername: National Health and Medical Research Council grantid: 1024879 – fundername: ; grantid: 1024879 |
GroupedDBID | --- .GJ 0R~ 23N 2WC 4.4 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EBD EBLON EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ INH INR ITC KQ8 M1P O5R O5S O9- PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A UKHRP WOQ CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c563t-5f7cc983fe8bf69031038bbd68970353816edb51736f0626ebc7c10f320ab1c73 |
IEDL.DBID | DOA |
ISSN | 1478-6362 1478-6354 |
IngestDate | Wed Aug 27 01:31:24 EDT 2025 Thu Aug 21 13:47:31 EDT 2025 Mon Jul 21 11:57:59 EDT 2025 Wed Aug 20 03:02:21 EDT 2025 Tue Jun 17 21:25:50 EDT 2025 Tue Jun 10 20:39:11 EDT 2025 Thu Apr 03 07:04:34 EDT 2025 Tue Jul 01 04:00:55 EDT 2025 Thu Apr 24 22:49:46 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | HLA Ankylosing spondylitis Association |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-5f7cc983fe8bf69031038bbd68970353816edb51736f0626ebc7c10f320ab1c73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/3b3192b3a152432c80f148b2c691dde0 |
PMID | 32272966 |
PQID | 2391273224 |
PQPubID | 42876 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_3b3192b3a152432c80f148b2c691dde0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7146985 proquest_miscellaneous_2388822248 proquest_journals_2391273224 gale_infotracmisc_A627331179 gale_infotracacademiconefile_A627331179 pubmed_primary_32272966 crossref_citationtrail_10_1186_s13075_020_02148_5 crossref_primary_10_1186_s13075_020_02148_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-04-09 |
PublicationDateYYYYMMDD | 2020-04-09 |
PublicationDate_xml | – month: 04 year: 2020 text: 2020-04-09 day: 09 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Arthritis research & therapy |
PublicationTitleAlternate | Arthritis Res Ther |
PublicationYear | 2020 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | S Purcell (2148_CR10) 2007; 81 HW van Deutekom (2148_CR19) 2015; 67 Z Lin (2148_CR11) 2011; 44 D Lopez Herraez (2148_CR7) 2009; 4 AR Roberts (2148_CR13) 2017; 114 A Cortes (2148_CR1) 2015; 6 JC Wei (2148_CR17) 2004; 43 WP Robinson (2148_CR14) 1989; 32 XQ Yu (2148_CR18) 2011; 44 L Yi (2148_CR3) 2013; 7 A Cortes (2148_CR6) 2011; 13 MA Brown (2148_CR16) 1996; 55 S van der Linden (2148_CR5) 1984; 27 A Cortes (2148_CR4) 2013; 45 DM Evans (2148_CR12) 2011; 43 S Das (2148_CR8) 2016; 48 K Kim (2148_CR2) 2015; 17 F Zhou (2148_CR9) 2016; 48 CM Wang (2148_CR20) 2012; 14 R Diaz-Pena (2148_CR15) 2016; 43 |
References_xml | – volume: 44 start-page: 178 issue: 2 year: 2011 ident: 2148_CR18 publication-title: Nat Genet doi: 10.1038/ng.1047 – volume: 43 start-page: 761 issue: 8 year: 2011 ident: 2148_CR12 publication-title: Nat Genet doi: 10.1038/ng.873 – volume: 114 start-page: 558 issue: 3 year: 2017 ident: 2148_CR13 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1618856114 – volume: 32 start-page: 1135 issue: 9 year: 1989 ident: 2148_CR14 publication-title: Arthritis Rheum doi: 10.1002/anr.1780320912 – volume: 7 start-page: 51 year: 2013 ident: 2148_CR3 publication-title: Open Rheumatol J doi: 10.2174/1874312920130628001 – volume: 81 start-page: 559 issue: 3 year: 2007 ident: 2148_CR10 publication-title: Am J Hum Genet doi: 10.1086/519795 – volume: 13 start-page: 101 issue: 1 year: 2011 ident: 2148_CR6 publication-title: Arthritis Res Ther doi: 10.1186/ar3204 – volume: 48 start-page: 740 issue: 7 year: 2016 ident: 2148_CR9 publication-title: Nat Genet doi: 10.1038/ng.3576 – volume: 48 start-page: 1284 issue: 10 year: 2016 ident: 2148_CR8 publication-title: Nat Genet doi: 10.1038/ng.3656 – volume: 44 start-page: 73 issue: 1 year: 2011 ident: 2148_CR11 publication-title: Nat Genet doi: 10.1038/ng.1005 – volume: 14 start-page: R125 issue: 3 year: 2012 ident: 2148_CR20 publication-title: Arthritis Res Ther doi: 10.1186/ar3855 – volume: 6 start-page: 7146 year: 2015 ident: 2148_CR1 publication-title: Nat Commun doi: 10.1038/ncomms8146 – volume: 43 start-page: 1255 issue: 6 year: 2016 ident: 2148_CR15 publication-title: J Rheumatol doi: 10.3899/jrheum.151096 – volume: 43 start-page: 839 issue: 7 year: 2004 ident: 2148_CR17 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keh193 – volume: 4 issue: 11 year: 2009 ident: 2148_CR7 publication-title: PLoS One doi: 10.1371/journal.pone.0007888 – volume: 27 start-page: 361 issue: 4 year: 1984 ident: 2148_CR5 publication-title: Arthritis Rheum doi: 10.1002/art.1780270401 – volume: 45 start-page: 730 issue: 7 year: 2013 ident: 2148_CR4 publication-title: Nat Genet doi: 10.1038/ng.2667 – volume: 17 start-page: 342 year: 2015 ident: 2148_CR2 publication-title: Arthritis Res Ther doi: 10.1186/s13075-015-0855-3 – volume: 55 start-page: 268 issue: 4 year: 1996 ident: 2148_CR16 publication-title: Ann Rheum Dis doi: 10.1136/ard.55.4.268 – volume: 67 start-page: 425 issue: 8 year: 2015 ident: 2148_CR19 publication-title: Immunogenetics doi: 10.1007/s00251-015-0849-y |
SSID | ssj0022924 |
Score | 2.3958032 |
Snippet | The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there is strong... Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease. Nonetheless, there... Abstract Background The association of HLA-B*27 with AS is amongst the strongest of any known association of a common variant with any human disease.... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 74 |
SubjectTerms | Alleles Amino acids Analysis Ankylosing spondylitis Arthritis Asian Continental Ancestry Group - genetics Asian people Asians Association China Gene Frequency Genetic Predisposition to Disease - ethnology Genetic Predisposition to Disease - genetics Genomics Genotype HLA HLA antigens HLA Antigens - genetics HLA-B27 Antigen - genetics HLA-C Antigens - genetics Humans Medical research Pathology Polymorphism, Single Nucleotide Republic of Korea Spondylitis, Ankylosing - ethnology Spondylitis, Ankylosing - genetics Taiwan |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifls9JYLgg4Rr2jRJn2TvuGMR1ycP9i3ko9HjpD23e6L_vTPZ7O4V4Z4KmwxtdmZ-M5NMZgh5rxwPZWkDc1FUEKDolrXBaaY9IKEFnodUXX_xVc7Pxedls8wbbmNOq9xiYgLqMHjcIz-q6paDqQWL8-nqF8OuUXi6mlto3CX3sHQZpnSp5T7gqtpNU1sBkRIYVrG9NKPl0QjYrfBucsmwaphmzcQwpfr9_6P0DTM1TaG8YZPOHpGH2Zmksw33H5M7Xf-E3F_k4_KnZFjMT6jdM2CkQ6S2v4QgHbcIKKbHhr-YADfSi56e2nFNZ3ircqR21dGUbt79AYoAw4BjvzvaDz2bf5mx40pReNKU6p57Zo3PyPnZ6beTOcsdFphvZL1mTVTet7qOnXYR4mRsOqadC1K3gAQNHip2wTVc1TKWEPp0zivPy1hXpXXcq_o5OYD3di8J5UpxH0JseQxCN9EJ68E7kE5pK9paFIRv_17jc_lx7ILx06QwREuzYYkBlpjEEtMU5OOO5mpTfOPW2cfItd1MLJydfhhW303WQ1M7kL_K1Rb8FlFXXpcRiF3lZcsB6cuCfECeG1Rv-Dxv8y0FWCQWyjIzWWGXS4CxghxOZoJa-unwVmpMhoXR7IW4IO92w0iJqW59N1zjHK3RaxO6IC82QrZbElBCMCRlQdRE_CZrno70Fz9S0XDFsVdo8-r2z3pNHlRJJwQr20NysF5dd2_A61q7t0m1_gH75CZ0 priority: 102 providerName: ProQuest |
Title | MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32272966 https://www.proquest.com/docview/2391273224 https://www.proquest.com/docview/2388822248 https://pubmed.ncbi.nlm.nih.gov/PMC7146985 https://doaj.org/article/3b3192b3a152432c80f148b2c691dde0 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA96gvgifls9lwiCDxKuSdskfdw99ljEPURc2LeQjwaPk65c947zv3cm7a5bBH3xZQubGdpkPjK_djJDyDvleMhzG5iLpQCAomtWB6eZ9uAJLcg8pOr6y3O5WJUf19X6oNUX5oT15YH7hTspHDAIV1jYaMpCeJ1HiOCd8LLmYJoJrcOetwNTA9QSACt2R2S0POnAUys8iZwzrBGmWTXahlK1_j998sGmNE6YPNiBzh6Rh0PoSKf9Iz8md5r2Cbm_HD6OPyWb5eKU2t_L3dFNpLa9BEiOLwQoJsOGn5ju1tGLls5tt6VTPEPZUXvV0JRc3twCR4Bh8Fo3DW03LVt8mrKZUBSuNCW2Dx2yumdkdTb_erpgQz8F5itZbFkVlfe1LmKjXQRUjC3GtHNB6hrsvsJPiE1wFVeFjDkAncZ55XkeC5Fbx70qnpMjuG_zklCuFPchxJrHUOoqutJ6iAWkU9qWdVFmhO-W1_ih2Dj2vPhuEujQ0vQiMSASk0Riqox82PP86Ett_JV6hlLbU2KZ7PQHKI8ZlMf8S3ky8h5lbtCY4fG8Hc4kwCSxLJaZSoE9LcFpZeR4RAlG6MfDO60xgxPojChqDgQQJGXk7X4YOTGxrW0210ijNcZopc7Ii17J9lMCToA-UmZEjdRvNOfxSHvxLZUIVxw7g1av_scivSYPRLKckuX1MTnaXl03byAS27oJuavWakLuzebnn79MkgnC70pMfwFnjC-1 |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJ8FeEN8EBhgJxAOyljhO7Dwg1I5OHWsrhDZpbya2EzYxJaPpgP5T_I3c5aNbhLS3PVWKfWmcO99HfHc_Qt5IEzjfTx0zueAQoKiEJc4opixowhR47uru-rN5PDkSn4-j4w3yt6uFwbTKTifWitqVFr-R7_AwCcDUgsX5eP6TIWoUnq52EBqNWBxkq98QslUf9j8Bf99yvjc-3J2wFlWA2SgOlyzKpbWJCvNMmRxiQwTaUsa4WCUg_REepGXORIEM49wHdz8zVtrAz0PupyawMoT73iKbIoRQZkA2R-P5l6_rEI8nDYyugNgMTLnoynRUvFOBtZBYDe0z7FOmWNQzhTViwP924Yph7CdtXrGCe_fI3dZ9pcNG3u6Tjax4QG7P2gP6h6ScTXZpesnyipY5TYsfq7MSP0pQTMh1K0y5q-hpQcdptaRDrOOsaLrIaJ3gnv0BCgfDoDl_ZbQoCzaZDtmISwq_tE6ub1G6qkfk6Ebe_mMygP_NnhIaSBlY5_IkyJ1QUW5EasEfiY1UqUhC4ZGge73atg3PEXfjTNeBj4p1wxINLNE1S3TkkfdrmvOm3ce1s0fItfVMbNVdXygX33W783VoQOK5CVPwlETIrfJzIDbcxkkAtsX3yDvkuUaFAo9n07YuAhaJrbn0MOaIqwmK0yPbvZmgCGx_uJMa3SqiSl9uG4-8Xg8jJSbXFVl5gXOUQj9RKI88aYRsvSSghPArjj0ie-LXW3N_pDg9qduUywDRSaNn1z_WK3Jncjib6un-_OA52eL1_hDMT7bJYLm4yF6Az7c0L9uNRsm3m97b_wDiumPD |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MHC+associations+of+ankylosing+spondylitis+in+East+Asians+are+complex+and+involve+non-HLA-B27+HLA+contributions&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Wang%2C+Geng&rft.au=Kim%2C+Tae-Hwan&rft.au=Li%2C+Zhixiu&rft.au=Cortes%2C+Adrian&rft.date=2020-04-09&rft.issn=1478-6362&rft.eissn=1478-6362&rft.volume=22&rft.issue=1&rft.spage=74&rft_id=info:doi/10.1186%2Fs13075-020-02148-5&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon |